UBS Group’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.3M | Sell |
578,950
-690,697
| -54% | -$33.7M | ﹤0.01% | 1601 |
|
|
2025
Q1 | $64.7M | Buy |
1,269,647
+198,596
| +19% | +$10.1M | 0.01% | 986 |
|
|
2024
Q4 | $48.3M | Buy |
1,071,051
+905,980
| +549% | +$40.9M | 0.01% | 1144 |
|
|
2024
Q3 | $6.12M | Buy |
165,071
+28,310
| +21% | +$1.05M | ﹤0.01% | 2093 |
|
|
2024
Q2 | $4.18M | Sell |
136,761
-88,699
| -39% | -$2.71M | ﹤0.01% | 2271 |
|
|
2024
Q1 | $6.56M | Sell |
225,460
-63,288
| -22% | -$1.84M | ﹤0.01% | 1944 |
|
|
2023
Q4 | $7.96M | Buy |
288,748
+210,883
| +271% | +$5.81M | ﹤0.01% | 1612 |
|
|
2023
Q3 | $1.74M | Sell |
77,865
-14,186
| -15% | -$318K | ﹤0.01% | 2654 |
|
|
2023
Q2 | $3.74M | Buy |
92,051
+15,229
| +20% | +$619K | ﹤0.01% | 2141 |
|
|
2023
Q1 | $3.72M | Sell |
76,822
-32,046
| -29% | -$1.55M | ﹤0.01% | 2077 |
|
|
2022
Q4 | $4.16M | Buy |
108,868
+78,107
| +254% | +$2.98M | ﹤0.01% | 1985 |
|
|
2022
Q3 | $1.54M | Sell |
30,761
-27,031
| -47% | -$1.36M | ﹤0.01% | 2539 |
|
|
2022
Q2 | $2.32M | Sell |
57,792
-84,177
| -59% | -$3.37M | ﹤0.01% | 2302 |
|
|
2022
Q1 | $5.3M | Buy |
141,969
+12,297
| +9% | +$459K | ﹤0.01% | 1886 |
|
|
2021
Q4 | $5.16M | Buy |
129,672
+66,850
| +106% | +$2.66M | ﹤0.01% | 2060 |
|
|
2021
Q3 | $2.34M | Buy |
62,822
+62,729
| +67,451% | +$2.33M | ﹤0.01% | 2642 |
|
|
2021
Q2 | $4K | Sell |
93
-32,879
| -100% | -$1.41M | ﹤0.01% | 7577 |
|
|
2021
Q1 | $1.56M | Buy |
32,972
+32,588
| +8,486% | +$1.54M | ﹤0.01% | 2978 |
|
|
2020
Q4 | $23K | Buy |
384
+90
| +31% | +$5.39K | ﹤0.01% | 5831 |
|
|
2020
Q3 | $14K | Sell |
294
-4,769
| -94% | -$227K | ﹤0.01% | 5717 |
|
|
2020
Q2 | $257K | Sell |
5,063
-66,826
| -93% | -$3.39M | ﹤0.01% | 3838 |
|
|
2020
Q1 | $3.21M | Buy |
71,889
+14,140
| +24% | +$631K | ﹤0.01% | 1802 |
|
|
2019
Q4 | $2.77M | Sell |
57,749
-28,857
| -33% | -$1.39M | ﹤0.01% | 2497 |
|
|
2019
Q3 | $2.93M | Buy |
86,606
+77,339
| +835% | +$2.62M | ﹤0.01% | 2298 |
|
|
2019
Q2 | $417K | Buy |
9,267
+411
| +5% | +$18.5K | ﹤0.01% | 3651 |
|
|
2019
Q1 | $334K | Sell |
8,856
-74,541
| -89% | -$2.81M | ﹤0.01% | 3587 |
|
|
2018
Q4 | $2.86M | Buy |
83,397
+53,298
| +177% | +$1.83M | ﹤0.01% | 2130 |
|
|
2018
Q3 | $1.42M | Buy |
30,099
+18,088
| +151% | +$850K | ﹤0.01% | 2865 |
|
|
2018
Q2 | $405K | Buy |
12,011
+1,713
| +17% | +$57.8K | ﹤0.01% | 3681 |
|
|
2018
Q1 | $279K | Sell |
10,298
-65,565
| -86% | -$1.78M | ﹤0.01% | 3785 |
|
|
2017
Q4 | $1.27M | Buy |
75,863
+12,150
| +19% | +$203K | ﹤0.01% | 2847 |
|
|
2017
Q3 | $1.28M | Buy |
63,713
+36,277
| +132% | +$726K | ﹤0.01% | 2829 |
|
|
2017
Q2 | $503K | Buy |
27,436
+3,123
| +13% | +$57.3K | ﹤0.01% | 3345 |
|
|
2017
Q1 | $239K | Buy |
24,313
+17,968
| +283% | +$177K | ﹤0.01% | 3727 |
|
|
2016
Q4 | $69K | Sell |
6,345
-2,765
| -30% | -$30.1K | ﹤0.01% | 4679 |
|
|
2016
Q3 | $128K | Buy |
9,110
+592
| +7% | +$8.32K | ﹤0.01% | 4017 |
|
|
2016
Q2 | $60K | Sell |
8,518
-37,487
| -81% | -$264K | ﹤0.01% | 4535 |
|
|
2016
Q1 | $296K | Buy |
46,005
+19,774
| +75% | +$127K | ﹤0.01% | 3501 |
|
|
2015
Q4 | $850K | Buy |
26,231
+16,531
| +170% | +$536K | ﹤0.01% | 2797 |
|
|
2015
Q3 | $259K | Buy |
9,700
+8,769
| +942% | +$234K | ﹤0.01% | 3539 |
|
|
2015
Q2 | $45K | Buy |
931
+21
| +2% | +$1.02K | ﹤0.01% | 4844 |
|
|
2015
Q1 | $55K | Sell |
910
-555
| -38% | -$33.5K | ﹤0.01% | 4582 |
|
|
2014
Q4 | $76K | Buy |
+1,465
| New | +$76K | ﹤0.01% | 4408 |
|